← Open Payments lookup

STEPHANIE JOHNSON: Open Payments

NPI 1841844685 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,069 in 85 payments from 10 companies in 2025. Trend: 2023 $1,744 · 2024 $2,725 · 2025 $2,069

Food & beverage: $2,069
CompanyPaymentsAmount
Madrigal Pharmaceuticals23$576
Gilead Sciences, Inc.14$550
Salix Pharmaceuticals, a division of Bausch Health US, LLC26$451
Ipsen Biopharmaceuticals, Inc7$147
ABBVIE INC.7$137
ORPHALAN INC4$114
Boehringer Ingelheim Pharmaceuticals, Inc.1$30
Takeda Pharmaceuticals U.S.A., Inc.1$28
Fujifilm Healthcare Americas Corporation1$23
Intercept Pharmaceuticals, Inc.1$14

Products named: REZDIFFRA, XIFAXAN, IQIRVO, CUVRIOR, MAVYRET, CREON, LIVTENCITY, UTASWAKO AFP-L3.

Industry payments across TX — which companies pay providers there.